MedPath

A phase II study of neoadjuvant chemotherapy with S-1 and oxaliplatin followed by surgery in cStageIII advanced gastric cancer patients

Phase 2
Recruiting
Conditions
Gastric cancer
Registration Number
JPRN-UMIN000023405
Lead Sponsor
Wakayama Medical University, Second Department of Surgery
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
48
Inclusion Criteria

Not provided

Exclusion Criteria

1) With active double or multiple cancers 2) Severe complications 3) With active infection 4) Positive HBs antigen or positive HCV antibody 5) Continuous systemic steroid therapy 6) Severe diarrhea 7) Past history of severe hypersensitivity to drugs 8) Under treatment with flucytosine 9) Under treatment with warfarin 10) Pregnant women, or women with the possibility of the pregnancy, Men who want let to pregnancy 11) Patients judged inappropriate for the study by the physicians

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath